AZN - AstraZeneca COVID prevention antibody gets EU fast-track review
2024-07-01 06:28:32 ET
AstraZeneca ( NASDAQ: AZN ) said Monday its marketing authorization application for its investigational COVID-19 prevention drug, sipavibart, has been accepted for an accelerated assessment by the EU drug regulator....
AstraZeneca COVID prevention antibody gets EU fast-track review